Purpose: The case of a 47-year-old female patient who underwent sigmoidectomy for metastatic colorectal cancer is reported. Treatment with capecitabine and 5-fluorouracil induced severe hypertriglyceridemia repeatedly.
Methods: Based on laboratory tests and clinical evaluations, treatment was suggested by specialists.
Findings: After treatment with capecitabine, the patient's triglycerides increased from 19.7 mmol/L to 42 mmol/L. It was proposed that the patient had multifactorial chylomicronemia syndrome triggered by secondary factors. Statins, fenofibrate, ezetimib, and metformin were added to the therapy. After metastases appeared, FOLFIRI (leucovorin calcium [folinic acid], 5-fluorouracil, and irinotecan hydrochloride) chemotherapy and biological treatment (cetuximab) followed and triglycerides increased to 55.3 mmol/L.
Implications: Monitoring triglyceride levels before and during therapy is suggested.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clinthera.2024.05.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!